Traits (such as eye color or risk for disease) are passed to your children by genes. Each person has two genes for each trait. One gene is from the mother and one gene is from the father. Autosomal recessive inheritance refers to conditions caused by changes (“mutations”) in genes located on one of the 22 pairs of autosomes. Autosomes are the numbered chromosomes that are the same in all males and females. Autosomal conditions occur in both men and women and are not related to whether a person is male or female. In an autosomal recessive disorder, two changed copies of a gene are inherited—one from each of the parents—which causes the child to have the disorder. The child is called “affected” because she or he has the disorder. A carrier has only one changed copy of the gene. They are called “carriers” of the trait because they do not show any signs of the disorder. Although they have one copy of a gene that is changed, the partner copy of the gene is working correctly, so they do not develop the disorder. When both parents are carriers for a recessive disorder, each child has a 1 in 4 (25 percent) chance of inheriting the two changed gene copies. A child who inherits two changed gene copies will be “affected,” meaning the child has the disorder. There is a 1 in 2 (50 percent) chance that the child will inherit one changed copy and one normal copy of the gene, and therefore be an unaffected carrier (just like the parent). There is a 1 in 4 (25 percent) chance that the child will inherit both normal copies of a gene, and be unaffected and not a carrier. If only one parent is a carrier and the other is not, none of the children will have the condition. But each child will have a 50 percent chance of being a carrier. For example, cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in a gene called CFTR. If both parents are carriers, each parent can pass on the changed copy or the normal copy to their children. Children who inherit two changed copies of the CFTR gene are “affected” and have the disease cystic fibrosis.
Genetic heredity is inherently probabilistic – sexual reproduction ensures that even when we know everything about the parents’ genomes, we don’t know what assortment of their genes will end up in each of their offspring. It can be fun to wonder if a new baby will look more like their mum or dad, but when a genetic condition runs in the family, the unpredictability can be worrying. We can, however, predict the possible outcomes based on chance. For example, for a couple who are both carriers of the gene variant for a recessive condition, the chance that their child will be affected is 25%. But it does not follow that if they have three healthy children, then the fourth will have the condition. They could have four healthy children, or four who are all affected. The 1-in-4 chance is the same each time, for each child. Penetrance and probabilityOften, the fact that a person carries a gene variant associated with a particular disease does not guarantee that they will be affected. For example, there is a wealth of evidence linking the BRCA genes to breast and ovarian cancers, but not every woman who carries a pathogenic variant on one of these genes will get cancer in her lifetime. Such genes are said to have incomplete penetrance. Around 12% of women in the general population will develop breast cancer at some point during their lives, and this goes up to 72% of women with a pathogenic variant in BRCA1 and about 69% of women with a pathogenic BRCA2 variant. So, while the risk is much greater for women with these gene variants, it is by no means certain. Conversely, many women develop breast cancers every year who do not carry these BRCA variants. In fact, because BRCA and other gene variants associated with breast cancer are comparatively rare, they only account for 5%-10% of all breast cancer diagnoses. Researchers have identified more than 100 other genes linked to increased risk of breast cancer, but none have effects as significant as the BRCA genes. We also know that environmental and lifestyle factors may affect the risk of developing breast cancer. But even if we had all this information, we still cannot predict whether an individual will develop cancer or not. There will always be rare individuals at high risk who remain unaffected, and individuals at low risk who develop the condition against the odds. Novel variantsSometimes a genetic condition can arise with absolutely no warning, when a de novo variant occurs in a gene. Achondroplasia is the most common form of dwarfism, affecting around one in 25,000 people. It is a genetic condition, resulting from a variant in a gene called FGFR3, and is inherited in an autosomal dominant pattern. It is 100% penetrant, so everyone who has the variant has achondroplasia. However, around 80% of people with achondroplasia do not inherit the condition from their parents; it is the result of a new variant that arises when the egg or sperm (or their precursor cells) were made. Because this is a random event, there is no way to predict when this will happen. Supporting the familyWhere a genetic condition appears to run in a family, a useful first step is to take a genetic family history (you can learn more about this in our short online course). A referral to clinical genetics may be appropriate, along with access to genetic counselling. For families who know they carry the gene variant for a genetic disease, options are available when it comes to family planning. Some couples opt for pre-implantation genetic testing (PGD) to select an unaffected embryo. Another option is prenatal testing during pregnancy to find out if their child will be affected, such as amniocentesis or CVS (chorionic villus sampling). Non-invasive tests are also being developed for some single-gene disorders. – Please note: This article is for informational or educational purposes, and does not substitute professional medical advice.Probability of Inheritance
Copyright � 1997-2012 by Dennis O'Neil. All rights reserved. |